Canada Pension Plan Investment Board
DAWN

Canada Pension Plan Investment Board’s Day One Biopharmaceuticals DAWN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$602K Sell
28,100
-10,400
-27% -$147K ﹤0.01% 1172
2025
Q4 		$359K Buy
+38,500
New +$322K ﹤0.01% 1438

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Canada Pension Plan Investment Board's DAWN Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Day One Biopharmaceuticals (DAWN) stake by 27% in Q1 2026, selling an estimated $147K and leaving 28,100 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Canada Pension Plan Investment Board first reported a position in DAWN in Q4 2025 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Canada Pension Plan Investment Board held 28,100 shares of Day One Biopharmaceuticals worth $602K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 10,400 Day One Biopharmaceuticals shares in Q1 2026, an estimated $147K.
  • Day One Biopharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1172 holding.
  • Canada Pension Plan Investment Board first reported a position in Day One Biopharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.